Adult lifetime cannabis use by country
Adult lifetime cannabis use by country[edit]

Adult lifetime cannabis use refers to the percentage of adults in a given country who have used cannabis at least once in their lifetime. This article provides an overview of adult lifetime cannabis use by country, highlighting the variations and trends observed globally.
Methodology[edit]
The data on adult lifetime cannabis use is primarily obtained through surveys conducted by various organizations and research institutions. These surveys typically involve representative samples of the adult population and aim to gather information on drug use patterns, including cannabis. The results are then analyzed to estimate the prevalence of cannabis use among adults in each country.
Global Overview[edit]
Cannabis use is a widespread phenomenon globally, with varying levels of prevalence across different countries. According to the World Drug Report published by the United Nations Office on Drugs and Crime (UNODC), approximately 3.8% of the global adult population, or around 188 million people, have used cannabis at least once in their lifetime.
Regional Variations[edit]
The prevalence of adult lifetime cannabis use varies significantly across different regions. In North America, for example, the United States has one of the highest rates of cannabis use, with around 16.9% of adults reporting lifetime use. Canada also has a relatively high prevalence, with approximately 14.9% of adults reporting cannabis use.
In Europe, the rates of adult lifetime cannabis use vary widely among countries. For instance, in the Netherlands, where cannabis policies are relatively lenient, the prevalence of lifetime use is estimated to be around 25.7%. On the other hand, countries like Sweden and Finland have lower rates, with approximately 6.4% and 5.5% of adults reporting cannabis use, respectively.
In South America, Uruguay stands out as the country with the highest prevalence of adult lifetime cannabis use, estimated to be around 31.8%. This can be attributed to the country's progressive cannabis legislation, which legalized both medical and recreational use.
Country-Specific Data[edit]
Below is a list of selected countries and their respective rates of adult lifetime cannabis use:
- United States: 16.9%
- Canada: 14.9%
- Netherlands: 25.7%
- Sweden: 6.4%
- Finland: 5.5%
- Uruguay: 31.8%
Please note that these figures are approximate and may vary depending on the source and methodology used in each survey.
Implications and Policy Considerations[edit]
The prevalence of adult lifetime cannabis use has significant implications for public health and drug policy. Countries with higher rates of cannabis use may face challenges related to addiction, mental health issues, and social consequences. On the other hand, countries with lower rates may focus on prevention and education programs to maintain these levels.
Policy considerations regarding cannabis use vary greatly across countries. Some nations have adopted more liberal approaches, such as decriminalization or legalization, while others maintain strict prohibitionist policies. These policy choices can influence the prevalence of cannabis use and its associated outcomes.
Conclusion[edit]
Adult lifetime cannabis use varies widely across countries, reflecting the complex interplay of cultural, social, and policy factors. Understanding these variations is crucial for policymakers, researchers, and public health professionals to develop effective strategies for addressing the potential risks and benefits associated with cannabis use.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian